---
title: "BullFrog AI Holdings regains Nasdaq equity compliance after $3.45M in equity raises"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281413568.md"
description: "BullFrog AI Holdings has regained compliance with Nasdaq's $2.5M stockholders' equity requirement after raising at least $3.45 million through common stock sales. The company received a notice of noncompliance but has now addressed the deficiency, reducing delisting risk. However, there are uncertainties regarding the outcome of the Nasdaq hearing and ongoing compliance."
datetime: "2026-04-01T19:03:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281413568.md)
  - [en](https://longbridge.com/en/news/281413568.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281413568.md)
---

# BullFrog AI Holdings regains Nasdaq equity compliance after $3.45M in equity raises

**BullFrog AI Holdings said it has regained compliance with Nasdaq's $2.5M stockholders' equity requirement after raising at least $3.45 million through sales of common stock.**

**Key Highlights:**

-   Received Nasdaq notice of noncompliance with Listing Rule 5550(b)(1) for minimum $2.5M equity; requested a hearing.
-   Completed sales under an at-the-market agreement and equity line, generating aggregate net proceeds of at least $3.45M.
-   Now believes it has stockholders’ equity above $2.5M, addressing the deficiency and potential delisting risk.
-   Notes forward-looking uncertainties about the Nasdaq hearing outcome and ongoing compliance.

Original SEC Filing: BullFrog AI Holdings, Inc. \[ BFRG \] - 8-K - Apr. 01, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BFRG.US](https://longbridge.com/en/quote/BFRG.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BFRGW.US](https://longbridge.com/en/quote/BFRGW.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)

## Related News & Research

- [Immix Biopharma Announces 95% Complete Response Rate In Interim Update From Relapsed/Refractory AL Amyloidosis Clinical Trial NEXICART-2](https://longbridge.com/en/news/287200923.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery](https://longbridge.com/en/news/287100303.md)
- [Guardant Health Says US FDA Approved Liquid Biopsy Test](https://longbridge.com/en/news/287069625.md)